Postdoctoral Research Associate

Manoja Rajalakshmi Aravindakshan

I build physiologically-grounded digital twins of human health and disease—predictive models that translate complex physiology into clinical insight and de-risk drug development. In parallel, I develop AI agents that accelerate how these models are constructed, calibrated, and refined.

Purdue University · Lilly–Purdue Research Collaboration maravind@purdue.edu LinkedIn GitHub
Manoja Rajalakshmi Aravindakshan

Research

Selected projects

Computational frameworks bridging physiology, pharmacokinetics, and AI-assisted model authoring.

Whole-body cardiovascular model

Whole-body cardiovascular digital twin

Closed-loop, lumped-parameter (RCR) network for whole-body hemodynamics—pressure, flow, and disease-state response.

Lumped-parameterHemodynamicsJAX
Whole-body lymphatic transport

Whole-body lymphatic transport

Comprehensive framework for interstitial and lymphatic drug transport—essential for subcutaneous biologics and immuno-oncology PK.

LymphaticsSubcutaneous PKODE
DigiLoCS liver-on-chip simulator

DigiLoCS — digital liver-on-chip

Predictive organ-on-chip simulator differentiating active vs. passive hepatic clearance for IVIVE. Published in PLOS ONE.

PBPKIVIVELiver-on-chip
Cranial-spinal CSF model

Cranial-spinal CSF & Circle of Willis

Coupled lumped-parameter model capturing Monro–Kellie volume coupling, intracranial pulsatility, and cerebrovascular regulation—relevant to intrathecal CNS delivery.

CNSIntrathecalCSF dynamics
Insulin-glucose modeling

Insulin–glucose dynamics in T2D

Extended oral minimal model with adipokine (leptin) and BMI coupling; identified three patho-clinical clusters in uncontrolled T2D patients.

MetabolismParameter estimationClustering
DSL + AI agents

PBPK DSL + AI agents

A domain-specific language for compartmental PK models that integrates a hierarchy of AI agents into the Design–Make–Test–Analyze (DMTA) cycle.

DSLAI agentsDMTA